Compared to Estimates, Molina (MOH) Q3 Earnings: A Look at Key Metrics

Core Insights - Molina (MOH) reported $11.48 billion in revenue for Q3 2025, marking an 11% year-over-year increase, but EPS fell to $1.84 from $6.01 a year ago, indicating a significant decline in profitability [1] - The revenue exceeded the Zacks Consensus Estimate of $10.9 billion by 5.28%, while the EPS fell short of the consensus estimate of $3.97 by 53.65% [1] Financial Performance Metrics - Molina's total Membership Care Ratio (MCR) was 92.6%, surpassing the average estimate of 90.3% [4] - The MCR for Medicare was reported at 93.6%, exceeding the estimated 87% [4] - The MCR for Marketplace was 95.6%, compared to the estimated 84.7% [4] Membership and Revenue Breakdown - Total ending membership was 5.63 million, slightly below the average estimate of 5.74 million [4] - Medicaid membership stood at 4.64 million, compared to the estimated 4.8 million [4] - Premium revenue reached $10.84 billion, exceeding the estimate of $10.31 billion, reflecting an 11.8% increase year-over-year [4] - Premium tax revenue was $506 million, slightly above the estimate of $474.87 million, but showed a year-over-year decline of 0.4% [4] - Medicare premium revenue was $1.61 billion, surpassing the estimate of $1.48 billion, with a year-over-year increase of 17.8% [4] - Medicaid premium revenue was $8.02 billion, exceeding the estimate of $7.66 billion, reflecting a 4.5% year-over-year increase [4] - Marketplace premium revenue was $1.2 billion, significantly above the estimate of $1.1 billion, showing an impressive 81.6% increase year-over-year [4] - Investment income was reported at $108 million, exceeding the estimate of $99.93 million, but reflecting an 8.5% year-over-year decline [4] - Other revenue was $22 million, slightly above the estimate of $21.47 million, with a year-over-year increase of 10% [4] Stock Performance - Molina's shares have returned +7.8% over the past month, outperforming the Zacks S&P 500 composite's +1.1% change [3] - The stock currently holds a Zacks Rank 4 (Sell), indicating potential underperformance relative to the broader market in the near term [3]